Global Women's Health Academy

Genetic Testing Using Novel Technologies of ART

    World population prospects were presented at the United Nations in 2013 and addressed directly global fertility projections. Fertility rates for ma...

    Released:

    • Overview

      World population prospects were presented at the United Nations in 2013 and addressed directly global fertility projections. Fertility rates for many developed countries continue to decline and are projected to do so for the foreseeable future. As part of updating of the WHO Global Guidelines for infertility diagnosis, management and interventions for treatment initiated in January 2012, Guideline Development Groups were assembled. These focus on female subfertility; male subfertility, ovarian stimulation for ART, IVF and ICSI, IUI with and without ovarian stimulation, polycystic ovary syndrome (PCOS); endometriosis, fertility interventions; and environmental effects on fertility, with the call to enhance fertility awareness at the country, if not regional, level.1,2 

      Substantial educational and practice needs have been identified demonstrating how poor understanding of myriad causes of male and female infertility by clinicians results in their failure to appropriately consider the full value offered to affected women through assisted reproductive technologies (ARTs).

      This module addresses for the participant genetic testing for both males and females, also focusing on female infertility anomalies; and describes in detail the roles played by PGD and PGS.

    • Learning Objectives

      At the completion of this module, participants will be better able to:

      1. Properly apply genetic testing for infertile men and women
      2. Identify genetic and molecular anomalies associated with infertility
      3. Routinely incorporate preimplantation genetic diagnosis and preimplantation genetic screening in their clinical practice
    • Commercial Support

      This activity is supported by an independent educational grant from Merck KGaA, Darmstadt, Germany.
       
      Original Release Date: 13 January 2015
      Expiration Date: 13 January 2017

       

      Contact Information

      In case of technical needs, please contact: info@globalfertilityacademy.org

    • Disclosure of Conflicts of Interest

      COURSE DIRECTOR

      Pasquale Patrizio, MD, MBE, HCLD
      Professor Obstetrics and Gynecology 
      Director, Yale Fertility Center
      Yale University
      New Haven, CT
      Financial Relationship Disclosure
      Advisor: EMD Serono

      AUTHORS

      Başak Balaban, MSc 
      Head of IVF Laboratory
      VKF American Hospital
      Istanbul, Turkey
      Financial Relationship Disclosure
      No relationship reported

      Alla Kalugina, MD, PhD
      Professor, Department of Obstetrics and Gynecologist and 
      Women Reproductive Health of SPb Medical Academy for Postgraduate Studies
      Deputy Head Doctor on Reproductive Medicine 
      AVA-Peter Clinic
      Saint-Petersburg, Russia
      Financial Relationship Disclosure
      No relationship reported

      Filippo Maria Ubaldi, MD, MSc
      Clinical Director
      Genera Center for Reproductive Medicine, Valle Giulia Clinic
      Roma, Italy
      Financial Relationship Disclosure
      Research Grants: Merck Serono
      Consultant: MSD

      REVIEWER

      Michael J. Tucker, PhD, FIBiol, HCLD
      IVF Laboratory Director
      Shady Grove Fertility RSC
      Rockville, MD
      Financial Relationship Disclosure
      No relationship reported

    Facebook Comments

    Sign-up for the Global Women's Health Academy newsletters.
    Comprehensive Women's Health Education.

    Better education for a better you.

    * Required
    Optional